The case for investing in healthcare startups
Despite their immense potential and positive impact, such startups struggle to attract funding
SINGAPORE has seen significant growth in the number of startups and investments in the healthcare technology sector. Last year, Singapore’s healthtech startups raised US$409 million, with deal volume doubling from the previous year.
Across the globe, countries grapple with ageing populations, rising chronic disease burdens, and increasing healthcare costs. Conventional healthcare systems struggle to meet these demands – leaving room for startups that offer more efficient, cost-effective and patient-centric solutions.
Such startups harness innovations to tackle problems in traditional healthcare systems, improving patient outcomes, widening access and enhancing quality of care.
Share with us your feedback on BT's products and services
